ORF_ID	CONTIG	START	STOP	ORIENTATION	CUT_OFF	PASS_EVALUE	Best_Hit_evalue	Best_Hit_ARO	Best_Identities	ARO	ARO_name	Model_type	SNP	Best_Hit_ARO_category	ARO_category	PASS_bitscore	Best_Hit_bitscore	bit_score	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	LABEL	ID	Model_id
BGC0000771.1|Lipo-oligosaccharide_3	ID=1_3;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.249	1608	2777	+	Loose	n/a	7.4265	vanSB	44.83	ARO:3003100, ARO:3000849, ARO:3002932, ARO:3002832, ARO:3003578, ARO:3003102	SFH-1, cphA4, vgaD, cphA6, PmrF, vanSB	protein homolog model	n/a	determinant of resistance to glycopeptide antibiotics; antibiotic resistance gene cluster, cassette, or operon; protein(s) conferring antibiotic resistance via molecular bypass	antibiotic inactivation enzyme; antibiotic resistance gene cluster, cassette, or operon; determinant of beta-lactam resistance; determinant of polymyxin resistance; determinant of resistance to glycopeptide antibiotics; efflux pump complex or subunit conferring antibiotic resistance; gene altering cell wall charge; protein(s) conferring antibiotic resistance via molecular bypass	450	24.6386	24.2534, 25.7942, 24.6386, 25.7942, 38.5058, 24.6386	ATGAAGAAAATAGGTGTAGTTATACCAATCTATAATGTAGAAAAATATTTAAGAGAATGTTTAGATAGCGTTATCAATCAAACTTATACTAACTTAGAAATCATACTTGTCAATGATGGTAGCACAGATGAACACTCACTCAATATTGCAAAAGAATATACCTTAAAAGATAAAAGAATAACTCTTTTTGATAAGAAAAATGGGGGTTTAAGTTCAGCTAGAAATATAGGTATAGAATACTTTAGCGGGGAATATAAATTAAAAAACAAAACTCAACATATAAAAGAAAATTCTTTAATAGAATTTCAATTGGATGGTAATAATCCTTATAATATATATAAAGCATATAAAAGCTCTCAAGCTTTTAATAATGAAAAAGATTTAACCAATTTTACTTACCCTAGTATAGATTATATTATATTCTTAGATAGTGATAATTATTGGAAACTAAACTGCATAGAAGAATGCGTTATAAGAATGAAAAATGTGGATGTATTGTGGTTTGACCATGATTGCACCTATGAAGACAATATAAAAAATAAGCACAAAAAAACAAGGATGGAAATTTTTGATTTTAAAAAAGAATGTATAATCACTCCAAAAGAATATGCAAATCGAGCATTAAGTGTAGGATCTAGAGATATTTCTTTTGGATGGAATGGAATGATTGATTTTAATTTTTTAAAGCAAATTAAACTTAAATTTATAAATTTTATTATCAATGAAGATATACACTTTGGGATAATTTTGTTTGCTAGTGCTAATAAAATTTATGTTTTATCACAAAAGTTGTATTTGTGTCGTTTAAGAGCAAACAGTATATCAAATCATGATAAGAAGATTACAAAAGCAAATGTGTCAGAGTATTTTAAAGATATATATGAAACTTTCGGGGAAAACGCTAAGGAAGCAAAAAATTATTTAAAAGCAGCAAGCAGGGTTATAACTGCTTTAAAATTGATAGAATTTTTTAAAGATCAAAAAAACGAAAATGCACTTGCTATAAAAGAAACATTTTTACCTTGCTATGCCAAAAAAGCTTTAATGATTAAAAAATTTAAAAAAGATCCTTTAAATTTAAAGGAACAATTAGTTTTAATTAAACCTTTTATTCAAACAAAACTTCCTTATGATATTTGGAAATTTTGGCAAAAAATAAAAAATATTTAA	MKKIGVVIPIYNVEKYLRECLDSVINQTYTNLEIILVNDGSTDEHSLNIAKEYTLKDKRITLFDKKNGGLSSARNIGIEYFSGEYKLKNKTQHIKENSLIEFQLDGNNPYNIYKAYKSSQAFNNEKDLTNFTYPSIDYIIFLDSDNYWKLNCIEECVIRMKNVDVLWFDHDCTYEDNIKNKHKKTRMEIFDFKKECIITPKEYANRALSVGSRDISFGWNGMIDFNFLKQIKLKFINFIINEDIHFGIILFASANKIYVLSQKLYLCRLRANSISNHDKKITKANVSEYFKDIYETFGENAKEAKNYLKAASRVITALKLIEFFKDQKNENALAIKETFLPCYAKKALMIKKFKKDPLNLKEQLVLIKPFIQTKLPYDIWKFWQKIKNI	MERKGIFIKVFSYTIIVLLLLVGVTATLFAQQFVSYFRAMEAQQTVKSYQPLVELIQNSDRLDMQEVAGLFHYNNQSFEFYIEDKEGSVLYATPNADTSNSVRPDFLYVVHRDDNISIVAQSKAGVGLLYQGLTIRGIVMIAIMVVFSLLCAYIFARQMTTPIKALADSANKMANLKEVPPPLERKDELGALAHDMHSMYIRLKETIARLEDEIAREHELEETQRYFFAAASHELKTPIAAVSVLLEGMLENIGDYKDHSKYLRECIKMMDRQGKTISEILELVSLNDGRIVPIAEPLDIGRTVAELLPDFQTLAEANNQRFVTDIPAGQIVLSDPKLIQKALSNVILNAVQNTPQGGEVRIWSEPGAEKYRLSVLNMGVHIDDTALSKLFIPFYRIDQARSRKSGRSGLGLAIVQKTLDAMSLQYALENTSDGVLFWLDLPPTSTL	BGC0000771.1|Lipo-oligosaccharide_3#1609#2778#1#ID=1_3;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.249	gnl|BL_ORD_ID|1277|hsp_num:0	499
BGC0000771.1|Lipo-oligosaccharide_1	ID=1_1;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.260	56	1312	+	Loose	n/a	1.66047	PmrF	28.57	ARO:3003578	PmrF	protein homolog model	n/a	determinant of polymyxin resistance; gene altering cell wall charge	determinant of polymyxin resistance; gene altering cell wall charge	600	26.9498	26.9498	ATGAATCTAAAGCAAATAAGCGTTATTATCATCGTAAAAAATGCTGAGCAAACTTTGCTTGAGTGTTTAAATTCTTTAAAAGATTTTGATGAAATTATTTTACTTAACAATGAAAGCATTGATAATACCCTAAATATAGCTAATAAATTTAAAAAAGATTTTGCTAATTTATATATTTATCACAATGCTTTTATAGGTTTTGGAGCTTTAAAAAATCTTGCTTTAAGTTATGCAAAAAATGATTGGATTTTAAGCATTGATGCTGATGAAGTGCTTGAAAATGAGTGTATTAAAGAGCTTAAAAATTTAAAACTTCAAGAAGATAATATCATCGCACTTAGCCGTAAAAATCTCTATAAAGGCGAATGGATAAAGGCATGTGGTTGGTGGCCTGATTATGTTTTGAGAATTTTTAATAAAAATTTCACTCGTTTTAATGATAATTTAGTACATGAAAGCCTTGTTTTGCCAAGTAATGCTAAAAAAATTTATCTTAAAAATGGATTGAAGCATTATTCTTATAAGGATATCTCTCACTTAATTGACAAAATGCAGTACTACTCAAGTCTTTGGGCAAAACAAAATATACACAAAAAAAGTGGTGTTTTAAAAGCAAATTTAAGAGCTTTTTGGACTTTTTTTAGAAATTATTTTTTAAAAAATGGCTTTTTATATGGTTATAAGGGTTTTATAATTAGCGTTTGTTCTGCATTGGGAACATTTTTTAAATATATGAAATTATATGAACTTCAAAGACAAAAACCAAAAACTTGCGCTTTAATAATAATAACTTATAATCAAAAAGAACGCCTTAAACTAGTGCTTGATAGTGTTAAAAATCTAGCCTTTTTACCCAATGAAGTTTTAATCGCAGATGATGGTAGCAAAGAAGATACAGCAAGGCTTATTGAAGAATATCAAAAAGATTTTCCTTGTCCTTTAAAACACATTTGGCAAGAAGATGAAGGGTTTAAACTTAGTAAAAGTCGCAACAAAACTATAAAAAACGCTGATAGTGAATATATAATAGTTATTGATGGTGATATGATTTTGGAAAAAGATTTCATAAAAGAACATTTAGAATTTGCACAAAGAAAGCTTTTTTTACAAGGTTCAAGAGTAATTTTAAATAAAAAAGAAAGCGAAGAAATTTTAAACAAAGATGATTATCGCATAATTTTTAATAAAAAAGATTTTAAAAGTTCTAAAAATTCTTTTTTAGCTAAAATATTTTACAGTCTTTCAAAAAAAAGATGA	MNLKQISVIIIVKNAEQTLLECLNSLKDFDEIILLNNESIDNTLNIANKFKKDFANLYIYHNAFIGFGALKNLALSYAKNDWILSIDADEVLENECIKELKNLKLQEDNIIALSRKNLYKGEWIKACGWWPDYVLRIFNKNFTRFNDNLVHESLVLPSNAKKIYLKNGLKHYSYKDISHLIDKMQYYSSLWAKQNIHKKSGVLKANLRAFWTFFRNYFLKNGFLYGYKGFIISVCSALGTFFKYMKLYELQRQKPKTCALIIITYNQKERLKLVLDSVKNLAFLPNEVLIADDGSKEDTARLIEEYQKDFPCPLKHIWQEDEGFKLSKSRNKTIKNADSEYIIVIDGDMILEKDFIKEHLEFAQRKLFLQGSRVILNKKESEEILNKDDYRIIFNKKDFKSSKNSFLAKIFYSLSKKR	MFEIHPVKKVSVVIPVYNEQESLPELIRRTTTACESLGKEYEILLIDDGSSDNSAHMLVEASQAENSHIVSILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEGYDVVGTVRQNRQDSWFRKTASKMINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHERSTFIPILANIFARRAIEIPVHHAEREFGESKYSFMRLINLMYDLVTCLTTTPLRMLSLLGSIIAIGGFSIAVLLVILRLTFGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYTDVRARPRYFVQQVIRPSSKENE	BGC0000771.1|Lipo-oligosaccharide_1#57#1313#1#ID=1_1;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.260	gnl|BL_ORD_ID|1861|hsp_num:0	2014
BGC0000771.1|Lipo-oligosaccharide_6	ID=1_6;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.244	4870	5745	+	Loose	n/a	2.62422	mtrR	29.41	ARO:3002574, ARO:3002559, ARO:3000817, ARO:3000363	EreB, mtrR, AAC(6')-Ip, AAC(6')-Iaf	protein homolog model	n/a	protein(s) and two-component regulatory system modulating antibiotic efflux	antibiotic inactivation enzyme; determinant of aminoglycoside resistance; determinant of macrolide resistance; protein(s) and two-component regulatory system modulating antibiotic efflux	700	25.409	25.0238, 25.0238, 25.409, 25.0238	ATGAAAAAAGTTATTATTGCTGGAAATGGACCAAGTTTAAAAGAAATTGATTATTCAAGACTACCAAATGATTTTGATGTATTTAGATGTAATCAATTTTATTTTGAAGATAAATACTATCTTGGTAAAAAATGCAAGGCAGTATTTTACAATCCTATTCTTTTTTTTGAACAATACTACACTTTAAAACATTTAATCCAAAATCAAGAATATGAGACCGAACTAATTATGTGTTCTAATTACAACCAAGCTCATCTAGAAAATGAAAATTTTGTAAAAACTTTTTACGATTATTTTCCTGATGCTCATTTGGGATATGATTTTTTCAAACAACTTAAAGATTTTAATGCTTATTTTAAATTTCACGAAATTTATTTCAATCAAAGAATTACCTCAGGGGTCTATATGTGTGCAGTAGCCATAGCCCTAGGATACAAAGAAATTTATCTTTCGGGAATTGATTTTTATCAAAATGGGTCATCTTATGCTTTTGATACTAAACAAAAAAATCTTTTAAAATTGGCTCCTAATTTTAAAAATGATAATTCACACTATATCGGACATAGTAAAAATACAGATATAAAAGCTTTAGAATTTCTAGAAAAAACTTACAAAATAAAACTATATTGCTTATGTCCTAACAGTCTTTTAGCAAATTTTATAGAACTAGCGCCAAATTTAAATTCAAATTTTATCATACAAGAAAAAAATAACTACACTAAAGATATACTCATACCTTCTAGTGAGGCTTATGGAAAATTTTCAAAAAATATTAATTTTAAAAAAATAAAAATTAAAGAAAATATTTATTACAAGTTGATAAAAGATCTATTAAGATTACCTAGTGATATAAAGCATTATTTCAAAGGAAAATAA	MKKVIIAGNGPSLKEIDYSRLPNDFDVFRCNQFYFEDKYYLGKKCKAVFYNPILFFEQYYTLKHLIQNQEYETELIMCSNYNQAHLENENFVKTFYDYFPDAHLGYDFFKQLKDFNAYFKFHEIYFNQRITSGVYMCAVAIALGYKEIYLSGIDFYQNGSSYAFDTKQKNLLKLAPNFKNDNSHYIGHSKNTDIKALEFLEKTYKIKLYCLCPNSLLANFIELAPNLNSNFIIQEKNNYTKDILIPSSEAYGKFSKNINFKKIKIKENIYYKLIKDLLRLPSDIKHYFKGK	MRKTKTEALKTKEHLMLAALETFYRKGIARTSLNEIAQAAGVTRGALYWHFKNKEDLFDALFQRICDDIENCIAQDAADAEGGSWTVFRHTLLHFFERLQSNDIYYKFHNILFLKCEHTEQNAAVIAIARKHQAIWREKITAVLTEAVENQDLADDLDKETAVIFIKSTLDGLIWRWFSSGESFDLGKTAPRIIGIMMDNLENHPCLRRK	BGC0000771.1|Lipo-oligosaccharide_6#4871#5746#1#ID=1_6;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.244	gnl|BL_ORD_ID|1541|hsp_num:0	2033
BGC0000771.1|Lipo-oligosaccharide_2	ID=1_2;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.239	1362	1604	+	Loose	n/a	5.21824	OXA-258	40.91	ARO:3002762, ARO:3002755, ARO:3002757, ARO:3001503, ARO:3002778, ARO:3002756, ARO:3002732, ARO:3002786, ARO:3002716, ARO:3002714	QnrB74, QnrB66, QnrB47, QnrB42, QnrB41, OXA-258, QnrB3, QnrB17, QnrB1, QnrB40	protein homolog model	n/a	antibiotic inactivation enzyme; determinant of beta-lactam resistance	antibiotic inactivation enzyme; antibiotic target protection protein; determinant of beta-lactam resistance; determinant of fluoroquinolone resistance	400	21.9422	21.1718, 21.1718, 21.1718, 21.9422, 21.1718, 21.557, 21.557, 21.1718, 21.557, 21.557	ATGAGTTTTTTTAAAACTGATTTTGATGAACTTGATGGTTTTAATGAAAATTTTATTGGTTGGGGTAGAGAAGATAGTGAATTTGTTGCTAGATTTTTATTTAATAAAGGCATTTTTAGACGATTAAAATTTAAAGCTATTGCTTATCATATTTATCACAAAGAAAATAGCAAAAAAATGCTTGAAAGCAATCATCAAATTTATTTAGATACCATCAAAAATAAAAAGATTTCTTGGAGATAA	MSFFKTDFDELDGFNENFIGWGREDSEFVARFLFNKGIFRRLKFKAIAYHIYHKENSKKMLESNHQIYLDTIKNKKISWR	MTVRLVSRALGAVLFASALTLPARADVLCTLVADAADGRILFQQGTRQDCTQRYTPASTFKLPIALMGADAGILQGPHQPVWNYQPAYPDWGGEAWRQPTDPARWIKYSVVWYSQLTARALGQERFQRYTSAFGYGNADVSGEPGKHNGTDGAWIISSLRISPFEQVDFLRKFVNRQLPVKAAAYDLAENLFEVGEADGWRLYGKTGTGSPGSHGVYTPANAYGWFVGWARKDDRQLVFARLLQDEGATQPNAGLRARDGLMRDWAAMVAAPRK	BGC0000771.1|Lipo-oligosaccharide_2#1363#1605#1#ID=1_2;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.239	gnl|BL_ORD_ID|1891|hsp_num:0	1659
BGC0000771.1|Lipo-oligosaccharide_5	ID=1_5;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.237	3876	4781	-	Loose	n/a	1.69915e-05	PmrF	29.31	ARO:3002159, ARO:3002162, ARO:3002866, ARO:3002868, ARO:3002161, ARO:3002156, ARO:3003578, ARO:3002869, ARO:3004036, ARO:3002157, ARO:3004086	tetB(60), dfrD, FOX-10, dfrG, APH(3')-VIII, dfrK, PmrF, FOX-5, FOX-3, FOX-2, FOX-8	protein homolog model	n/a	determinant of polymyxin resistance; gene altering cell wall charge	antibiotic inactivation enzyme; antibiotic target replacement protein; determinant of aminoglycoside resistance; determinant of beta-lactam resistance; determinant of diaminopyrimidine resistance; determinant of polymyxin resistance; efflux pump complex or subunit conferring antibiotic resistance; gene altering cell wall charge	350	41.5874	25.0238, 25.0238, 24.2534, 23.8682, 24.2534, 24.6386, 41.5874, 29.6462, 24.6386, 24.2534, 23.8682	ATGTTTAAAATTTCAATCATCTTACCAACTTATAATGTGGAACAATATATAGCAAGGGCAATAGAAAGCTGTATCAATCAGACTTTTAAAGATATAGAAATAATTGTAGTTGATGATTGTGGAAATGATAATAGTATAAATATAGCCAAAGAATACTCTAAAAAAGACAAAAGAATAAAAATAATCCACAATGAAAAAAACTTAGGTCTTTTAAGAGCAAGATATGAAGGTGTGAAAGTAGCAAACTCTCCTTATATAATGTTTTTAGATCCTGATGATTATTTGGAACTAAATGCTTGTGAAGAGTGTATAAAAATTTTAGATGAACAGGATGAAGTTGATTTAGTGTTTTTCAATGCTATTGTTGAAAGTAATGTTATTTCATATAAAAAGTTTGACTTTAATTCTGGTTTTTATAGCAAAAAAGAGTTTGTAAAAAAAATTATTGCAAAGAAAAATTTATATTGGACTATGTGGGGGAAACTTATAAGAAAGAAATTGTATTTAGAAGCTTTTGCGAGTTTAAGACTCGAGAAAGATGTTAAAATCAATATGGCTGAAGATGTATTGTTATATTATCCAATGTTAAGTCAAGCTCAAAAAATAGCATATATGAACTGTAATTTATATCATTACGTGCCTAATAATAATTCAATTTGTAATACTAAGAATGAAGTGCTTGTTAAAAATAATATTCAAGAGTTGCAGTTGGTTTTAAACTATTTAAGGCAAAATTATATTTTAAACAAGTATTGTAGCGTTCTCTATGTGCTAATTAAATATTTGCTATATATTCAAATATATAAAATAAAAAGAACAAAATTAATGGTTACATTATTAGCTAAAATAAATATTTTAACTTTAAAAATTTTATTTAAATATAAAAAATTTTTAAAACAATGTTAA	MFKISIILPTYNVEQYIARAIESCINQTFKDIEIIVVDDCGNDNSINIAKEYSKKDKRIKIIHNEKNLGLLRARYEGVKVANSPYIMFLDPDDYLELNACEECIKILDEQDEVDLVFFNAIVESNVISYKKFDFNSGFYSKKEFVKKIIAKKNLYWTMWGKLIRKKLYLEAFASLRLEKDVKINMAEDVLLYYPMLSQAQKIAYMNCNLYHYVPNNNSICNTKNEVLVKNNIQELQLVLNYLRQNYILNKYCSVLYVLIKYLLYIQIYKIKRTKLMVTLLAKINILTLKILFKYKKFLKQC	MFEIHPVKKVSVVIPVYNEQESLPELIRRTTTACESLGKEYEILLIDDGSSDNSAHMLVEASQAENSHIVSILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEGYDVVGTVRQNRQDSWFRKTASKMINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHERSTFIPILANIFARRAIEIPVHHAEREFGESKYSFMRLINLMYDLVTCLTTTPLRMLSLLGSIIAIGGFSIAVLLVILRLTFGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYTDVRARPRYFVQQVIRPSSKENE	BGC0000771.1|Lipo-oligosaccharide_5#3877#4782#-1#ID=1_5;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.237	gnl|BL_ORD_ID|1861|hsp_num:0	2014
BGC0000771.1|Lipo-oligosaccharide_4	ID=1_4;partial=00;start_type=ATG;rbs_motif=AGGA/GGAG/GAGG;rbs_spacer=11-12bp;gc_cont=0.240	2847	3890	+	Loose	n/a	1.67315	ACT-37	24.07	ARO:3002019, ARO:3003172, ARO:3002022, ARO:3001840, ARO:3002182, ARO:3002012, ARO:3001817, ARO:3002030, ARO:3002020, ARO:3001407, ARO:3002021, ARO:3002492	CMY-11, CMY-10, OXA-12, LRA-18, CMY-19, CMY-8, CMY-1, ACT-37, MOX-1, ACT-19, ACC-3, CMY-9	protein homolog model	n/a	antibiotic inactivation enzyme; determinant of beta-lactam resistance	antibiotic inactivation enzyme; determinant of beta-lactam resistance	750	26.5646	25.0238, 26.5646, 24.6386, 26.9498, 25.0238, 25.0238, 25.0238, 24.2534, 24.6386, 24.6386, 25.0238, 27.335	ATGCTATTTCAATCATACTTTGTGAAAATAATTTGCTTATTCATCCCTTTTAGAAAAATTAGACATAAAATAAAAAAAACATTTTTACTAAAAAACATACAACGAGATAAAATCGATTCTTATTTACCAAAAAAAACTCTTGTGCAAATTAATAAATACAACAATGAAGATTTAATTAAACTTAATAAAGCTATTATAGGGGAGGGGCATAAAGGATATTTTAATTATGATGAAAAATCTAAAGATCCAAAATCTCCTTTGAATCCTTGGGCTTTTATACGAGTAAAAAATGAAGCTATTACCTTAAAAGCTTCTCTTGAAAGCATATTGCCTGCTATCCAAAGAGGTGTTATAGGATATAATGATTGTACCGATGGAAGTGAAGAAATAATTCTAGAATTTTGCAAACAATATCCTTCATTTATACCAATAAAATATCCTTATGAAATTCAAATTCAAAACCCAAAATCAGAAGAAAATAAACTCTATAGCTATTATAATTATGTTGCAAGTTTTATACCAAAAGATGAGTGGCTTATAAAAATAGATGTGGATCATATCTATGATGCTAAAAAACTTTATAAAAGCTTCTATATACCAAAAAACAAATATGATGTAGTTAGTTATTCAAGGGTTGATATTCACTATTTTAATGATAATTTTTTTCTTTGTAAAGATAATAATGGCAATATATTGAAAGAACCAGGAGATTGCTTGCTTATCAATAATTATAACTTAAAATGGAAAGAAGTATTAATTGACAGAATCAATAACAATTGGAAAAAAGCAACAAAACAAAGTTTTTCTTCAAATATACACTCTTTAGAGCAATTAAAGTATAAACACAGGATATTATTTCACACTGAATTAAATAATTATCATTTTCCTTTTTTAAAAAAACATAGAGCTCAAGATATTTATAAATATAATTGGATAAGTATTGAAGAATTTAAAAAATTCTATTTACAAAATATTAATCATAAAATAGAACCTTCTATGATTTCAAAAGAAACTCTAAAAAAAATATTCTTAACATTGTTTTAA	MLFQSYFVKIICLFIPFRKIRHKIKKTFLLKNIQRDKIDSYLPKKTLVQINKYNNEDLIKLNKAIIGEGHKGYFNYDEKSKDPKSPLNPWAFIRVKNEAITLKASLESILPAIQRGVIGYNDCTDGSEEIILEFCKQYPSFIPIKYPYEIQIQNPKSEENKLYSYYNYVASFIPKDEWLIKIDVDHIYDAKKLYKSFYIPKNKYDVVSYSRVDIHYFNDNFFLCKDNNGNILKEPGDCLLINNYNLKWKEVLIDRINNNWKKATKQSFSSNIHSLEQLKYKHRILFHTELNNYHFPFLKKHRAQDIYKYNWISIEEFKKFYLQNINHKIEPSMISKETLKKIFLTLF	MMKKSFCCALLLAISGAALAAPVSEKQLAEVVANTVTPLMKAQAIPGMAVAVIYQGKPHYYTFGEADIAAKKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVIKYWPELTGKQWQGIRMLDLATYTAGGLPLQVPEEVTDNASLLRFYQHWQPQWKPGTTRLYANASIGLFGALAVKPSGMRYEQAMTKRVFKPLRLNHTWINVPKAEAAHYAWGYRDGKAVHVSPGMLDAEAYGVKTNVQDMANWVMANMAPENVADASLKQGIALAQSRYWRIGSMYQGLGWEMLNWPVEAKTVIEGSDNKVALAPLPVAEVNPPVPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLANKSYPNPARVEAAYHILDALQ	BGC0000771.1|Lipo-oligosaccharide_4#2848#3891#1#ID=1_4;partial=00;start_type=ATG;rbs_motif=AGGA/GGAG/GAGG;rbs_spacer=11-12bp;gc_cont=0.240	gnl|BL_ORD_ID|367|hsp_num:0	257
